[Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
In the blood of 20 patients with prostatic carcinoma the level of alpha 2-antiplasmin and plasminogen were examined. The control group consisted of 20 patients with benign prostatic hyperplasia. The low activity of alpha 2-antiplasmin in the blood of the patients with prostatic carcinoma was observed. The level of plasminogen was similar in both groups and it was in the low part of laboratory normal range. We concluded that the low levels of plasminogen and alpha 2-antiplasmin were a result of their consumption during activation of fibrinolysis process. The measurement of the alpha 2-antiplasmin and plasminogen can be useful to predict a risk of bleeding complications in the patients with prostatic carcinoma and benign prostatic hyperplasia.
Zietek
Z
Z
Katedry i Kliniki Urologii, Katedry i Zakładu Patofizjologii Akademii Medycznej, Bydgoszczy.
Iwan-Zietek
I
I
Kotschy
M
M
Tyloch
F
F
D000368:Aged; D000369:Aged, 80 and over; D005343:Fibrinolytic Agents / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000097:blood*; D000979:alpha-2-Antiplasmin / Q000378:metabolism*
D005343:Fibrinolytic Agents; D000979:alpha-2-Antiplasmin; D010958:Plasminogen
Stezenie plazminogenu i alpha 2-antyplazminy we krwi chorych na raka gruczołu krokowego.